---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-044828"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T02:19:24.069450+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals enters CFO consulting agreement; $4k/month, 25k shares

## Summary
- Consulting agreement with CFO Eugene Johnston effective Oct 1, 2024 for 12 months.
- Cash compensation: $4,000 per month.
- Equity: 25,000 shares of common stock under 2022 Equity Incentive Plan, vested on execution.
- Agreement includes non-solicitation covenants and standard confidentiality.
- Johnston continues as CFO; no change in leadership role.

## SEC filing metadata
- accession: 0001493152-24-044828
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315224044828/0001493152-24-044828-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315224044828/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-044828
- JSON: https://secwatch.observer/filing/0001493152-24-044828.json
- Plain text: https://secwatch.observer/filing/0001493152-24-044828.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.